Home » Authors » Nuala Moran

Nuala Moran

Articles

ARTICLES

Arrow Spins Out Immunoprime To Focus On Infectious Disease

Jan. 5, 2005

GW Rebounds From UK Denial With Sativex Canadian Approval

Dec. 29, 2004

Pharmagene Shares Fall On Failed Phase IIa Study, Lower Guidance

Dec. 29, 2004

LONDON - Shares in Pharmagene plc dropped by one-quarter when the company announced its lead product, PGN0052, failed in a Phase IIa trial in cystic fibrosis and the company warned that 2004 revenues from its drug discovery services would be lower than 2003. (BioWorld International)

Pharmagene Shares Fall On Failed Phase IIa Study, Lower Guidance

Dec. 29, 2004

LONDON - Shares in Pharmagene plc dropped by one-quarter when the company announced its lead product, PGN0052, failed in a Phase IIa trial in cystic fibrosis and the company warned that 2004 revenues from its drug discovery services would be lower than 2003. (BioWorld International)

GW Rebounds From UK Denial With Sativex Canadian Approval

Dec. 29, 2004

CAT Wins Court Battle Over Humira; Abbott Logs Appeal

Dec. 22, 2004

CAT Wins Court Battle Over Humira; Abbott Logs Appeal

Dec. 22, 2004

Phytopharm Product, Not Good For Pharma, Aimed At Foods

Dec. 22, 2004

CAT Wins Court Battle Over Humira; Abbott Logs Appeal

Dec. 22, 2004

Phytopharm Product, Not Good For Pharma, Aimed At Foods

Dec. 22, 2004

View All Articles by Nuala Moran

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
First-in-class non-β-lactam targeting AMR gram-negative pathogens
BioWorld Science
Antimicrobial resistance (AMR) is increasingly compromising the effectiveness of essential antibiotics, resulting in higher global mortality and morbidity rates....